Castle Rock Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,831
Closed -$474K 228
2022
Q1
$474K Sell
7,831
-2,900
-27% -$173K 0.22% 133
2021
Q4
$635K Sell
10,731
-35,519
-77% -$2.27M 0.26% 116
2021
Q3
$3.02M Sell
46,250
-217,594
-82% -$13.9M 1.03% 18
2021
Q2
$2.75M Buy
263,844
+220,920
+515% +$12.8M 1.01% 17
2021
Q1
$2.56M Buy
42,924
+792
+2% +$43.9K 1.03% 14
2020
Q4
$2.37M Buy
42,132
+16,026
+61% +$838K 0.98% 18
2020
Q3
$1.34M Sell
26,106
-6,180
-19% -$299K 0.88% 32
2020
Q2
$1.57M Buy
32,286
+5,430
+20% +$232K 0.92% 25
2020
Q1
$1.15M Buy
26,856
+11,574
+76% +$487K 0.99% 20
2019
Q4
$697K Buy
+15,282
New +$642K 0.63% 59

Other funds holding IHI

Castle Rock Wealth Management's IHI Position: Q2 2022 in Review

Castle Rock Wealth Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 7,831 shares — an estimated $474K sold.

Castle Rock Wealth Management first reported a position in IHI in Q4 2019 and held it in 10 quarters. The position peaked at $3.02M in Q3 2021. 592 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • Castle Rock Wealth Management reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • Castle Rock Wealth Management sold 7,831 iShares US Medical Devices ETF shares in Q2 2022, an estimated $474K.
  • Castle Rock Wealth Management first reported a position in iShares US Medical Devices ETF in Q4 2019 and held it in 10 quarters.
  • Castle Rock Wealth Management's iShares US Medical Devices ETF position peaked at $3.02M in Q3 2021.
  • 592 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on Castle Rock Wealth Management's 13F filing for Q2 2022, filed 13 Jul 2022.